A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Public ClinicalTrials.gov record NCT00080210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout
Study identification
- NCT ID
- NCT00080210
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Savient Pharmaceuticals
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Puricase Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Not listed
- Completion
- Jan 31, 2005
- Last update posted
- Jun 2, 2013
2004 – 2005
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Spain Rehabilitation Center | Birmingham | Alabama | 35294 | — |
| University of California, San Diego | La Jolla | California | 92037 | — |
| University of Chicago Dept of Medicine | Chicago | Illinois | 60637 | — |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Center for Rheumatology and Bone Research | Wheaton | Maryland | 20902 | — |
| North Shore University Hospital Division of Rheumatology | Manhasset | New York | 11030 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Oregon Health & Science University Arthritis & Rheumatic Diseases | Portland | Oregon | 97239 | — |
| Pride Clinical research Associates | Pittsburgh | Pennsylvania | 15219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00080210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00080210 live on ClinicalTrials.gov.